ROLE OF NEUROMELANIN AND ALPHA-SINUCLEINE IN THE START AND EXTENSION OF PARKINSON DISEASE: DIAGNOSTIC AND THERAPEUTIC POTENTIAL IN NEW PRE-CLINICAL MODELS

Project Number
EUJPND-SpainISC-VILA BOVER-1392
Agency/Funding Organization
INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD
Funding Year
2016
View Full Project Details for ROLE OF NEUROMELANIN AND ALPHA-SINUCLEINE IN THE START AND EXTENSION OF PARKINSON DISEASE: DIAGNOSTIC AND THERAPEUTIC POTENTIAL IN NEW PRE-CLINICAL MODELS
Research Categorization
Primary Disease / Condition
Lewy Body Dementias
CADRO
Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs)
5. Other Proteinopathies
a. Alpha-Synuclein
Researcher and Organization
Principal Investigator
VILA BOVER, MIQUEL
Principal Investigator First Name
MIQUEL
Principal Investigator Last Name
VILA BOVER
Awardee Organization
FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Contact PI Country
Spain
Project Detail
Funding Opportunity Announcement
PLAN ESTATAL DE INVESTIGACIÓN CIENTÍFICA Y TÉCNICA Y DE INNOVACIÓN 2013-2016
FY Overall Cost
$47,593
Funding Organization
Agency/Funding Organization
INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD
Funding Organization Country
Spain
Special Initiative
EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)

You might be interested in other related resources and tools...